Showing results (91-100 of 263) with videos related to
Sort By:
Pageof 27
Cancer Investigation|January 1, 1985
Experimental studies and phase II trial of bisantrene in advanced urothelial malignanciesH I Scher, T Ahmed, A Yagoda, et al.European Journal of Cancer & Clinical Oncology|February 1, 1987
Neuron-specific enolase as a guide to the treatment of small cell lung cancerT A Splinter, E H Cooper, G S Kho, et al.Seminars in Oncology|January 14, 1998
A phase I dose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancerA van der Gaast, T C Kok, R Vos, et al.Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephromaH I Scher, A Yagoda, T Ahmed, et al.Cancer|December 15, 1992
Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapyD P Petrylak, H I Scher, Z Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancerW K Kelly, T Curley, C Leibretz, et al.Urology|May 1, 1996
Acid phosphatase: defining a role in androgen-independent prostate cancerG Steineck, W K Kelly, M Mazumdar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Inactivation of the p53 pathway in prostate cancer: impact on tumor progressionI Osman, M Drobnjak, M Fazzari, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladderD P Petrylak, H I Scher, V Reuter, et al.The Journal of Urology|April 1, 1985
Vinblastine and methotrexate for advanced bladder cancerT Ahmed, A Yagoda, B Needles, et al.Pageof 27